These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24393310)

  • 21. [Primary skin lymphomas: Current therapy].
    Dereure O
    Ann Dermatol Venereol; 2019 Feb; 146(2):92-99. PubMed ID: 30709635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management of cutaneous T-cell lymphomas: Recommendations of the French Cutaneous Lymphoma Group].
    Beylot-Barry M; Dereure O; Vergier B; Barete S; Laroche L; Machet L; Delfau-Larue MH; D'Incan M; Grange F; Ortonne N; Merlio JP; Bagot M;
    Ann Dermatol Venereol; 2010 Oct; 137(10):611-21. PubMed ID: 20932440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
    Whittaker SJ; Foss FM
    Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cutaneous B-cell lymphoma].
    Cortés B; Prins C
    Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on treatment of cutaneous T-cell lymphoma.
    Gardner JM; Evans KG; Musiek A; Rook AH; Kim EJ
    Curr Opin Oncol; 2009 Mar; 21(2):131-7. PubMed ID: 19532014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous B-cell lymphoma: classification and treatment.
    Willemze R
    Curr Opin Oncol; 2006 Sep; 18(5):425-31. PubMed ID: 16894288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
    Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Systemic treatment of cutaneous lymphomas].
    Klemke CD
    Hautarzt; 2011 Jun; 62(6):436-43. PubMed ID: 21656114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standard and new treatments in cutaneous B-cell lymphomas.
    Dreno B
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():47-51. PubMed ID: 16412212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment algorithms for mature T-cell and natural killer-cell neoplasms.
    Tse E; Kwong YL
    Future Oncol; 2011 Sep; 7(9):1101-12. PubMed ID: 21919697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
    Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
    J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas.
    Starz H; Balda BR; Bachter D; Büchels H; Vogt H
    Cancer; 1999 Jan; 85(1):199-207. PubMed ID: 9921993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience.
    Stefoni V; Broccoli A; Argnani L; Sabattini E; Cavo M; Zinzani PL
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):297-299. PubMed ID: 29500149
    [No Abstract]   [Full Text] [Related]  

  • 35. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.
    Senff NJ; Noordijk EM; Kim YH; Bagot M; Berti E; Cerroni L; Dummer R; Duvic M; Hoppe RT; Pimpinelli N; Rosen ST; Vermeer MH; Whittaker S; Willemze R; ;
    Blood; 2008 Sep; 112(5):1600-9. PubMed ID: 18567836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches.
    Querfeld C; Rosen ST; Kuzel TM; Guitart J
    Semin Cutan Med Surg; 2003 Sep; 22(3):150-61. PubMed ID: 14649582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group].
    Grange F; D'Incan M; Ortonne N; Dalac S; Laroche L; Beylot-Barry M; Delfau-Larue MH; Vergier B; Bagot M;
    Ann Dermatol Venereol; 2010; 137(8-9):523-31. PubMed ID: 20804896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current approaches to diagnosing and treating primary cutaneous lymphomas on the basis of a new WHO-EORTC classification, cutaneous T-cell lymphomas].
    Belousova IE; Kazakov DV; Krivolapov IuA
    Arkh Patol; 2007; 69(5):11-7. PubMed ID: 18074813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2013 Jan; 88(1):73-6. PubMed ID: 23379008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New aspects in the classification of cutaneous lymphomas].
    Erós N; Károlyi Z; Kovács A
    Orv Hetil; 2001 Feb; 142(8):393-8. PubMed ID: 11263077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.